Saved in:
Bibliographic Details
Main Author: MedicOath Autonomous Discovery Engine
Format: Recurso digital
Language:
Published: Zenodo 2026
Subjects:
Online Access:https://doi.org/10.5281/zenodo.19833082
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Adenoviral delivery of CD40L combined with recombinant IL-21 activates residual B-cells through CD40/TRAF6 and IL-21R/STAT3 pathways, bypassing defective BTK signaling to promote class switching and antibody production